Innovative People

Chris Stone

My current work focuses on the design and synthesis of novel antimicrobial compounds such as peptide mimetics and small molecule inhibitors. I study obligate Gram-negative organisms, targeting their virulence factor (namely type III secretion) for inhibition as an alternative to classical antibiotics.